way 100135 has been researched along with paroxetine in 2 studies
Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (paroxetine) | Trials (paroxetine) | Recent Studies (post-2010) (paroxetine) |
---|---|---|---|---|---|
143 | 0 | 34 | 4,257 | 1,031 | 1,031 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davidson, C; Stamford, JA | 1 |
Auerbach, SB; Hjorth, S | 1 |
2 other study(ies) available for way 100135 and paroxetine
Article | Year |
---|---|
The effect of paroxetine on 5-HT efflux in the rat dorsal raphe nucleus is potentiated by both 5-HT1A and 5-HT1B/D receptor antagonists.
Topics: Animals; Electric Stimulation; Male; Methiothepin; Oxadiazoles; Paroxetine; Piperazines; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Time Factors | 1995 |
Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Autoreceptors; Citalopram; Hippocampus; Male; Microdialysis; Paroxetine; Pindolol; Piperazines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stereoisomerism | 1994 |